Immunovia AB (publ) (0G8X.L)

1.4000 -0.0680 (-4.63%) At close: 11:13AM BST

Immunovia AB (publ)

Medicon Village
Scheelevägen 8
Lund 223 63
Sweden
46 4 62 75 60 00
https://www.immunovia.com

Sector(s): 
Industry: 
Full-time employees: 11

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jeff Borcherding	Global Chief Executive Officer & President	N/A	N/A	1973
Ms. Karin Almqvist Liwendahl	Chief Financial Officer	N/A	N/A	1962
Dr. Karl Stone	Chief Operating Officer	N/A	N/A	1963
Ms. Lara E. Sucheston-Campbell	Head of Clinical & Medical Affairs	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Immunovia AB (publ), a diagnostic company, develops and commercializes blood-based diagnostics for cancer in Sweden and internationally. It offers IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. The company was incorporated in 2007 and is headquartered in Lund, Sweden.

Corporate governance

Immunovia AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.